This site is intended for UK healthcare professionals

ATTR‑CM Series – Episode 1: Understanding Cardiac Amyloidosis

This non-promotional podcast has been developed and funded by Pfizer Ltd. and is intended for UK healthcare professionals only.
Dr Kate Gatenby provides an overview of cardiac amyloidosis, different types of cardiac amyloidosis and clinical red flags for ATTR-CM.

Share this episode:

Speaker

Dr Kate Gatenby, Cardiology Consultant, Leeds General Infirmary, UK

For more expert-led non-promotional content on heart failure, cardiac amyloidosis and ATTR-CM and other podcasts in the series, please visit the Pfizer Medical website. Clicking this link will redirect you to the Pfizer Medical website, a non-promotional website developed and funded by Pfizer Ltd. for UK healthcare professionals.

Abbreviation:
ATTR-CM: Transthyretin amyloid cardiomyopathy.

To continue, please confirm that you are a healthcare professional in the United Kingdom.